Finally, smac066 when combined with ABT-737 exhibited synergism implicating that targeting Bcl-2 family and IAP family proteins in parallel, could be a novel strategy to promote apoptosis in CLL. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.